Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006220:Haloperidol / Q000037:antagonists & inhibitors*; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013378:Substantia Nigra / Q000502:physiology*; D013570:Synaptic Membranes / Q000187:drug effects; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid; D008094:Lithium; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine